Davis. Quantitative Analysis of Biomarkers Defines an Optimal Biological Dose for Recombinant Human Endostatin in Primary Human Tumors. American Association for Cancer Research (AACR), Jan. 2004, doi:10.1158/1078-0432.ccr-0736-3.